ordinary shares with a par value of Baht 1 per share as follows: 1) To capital increase by the General Mandate of Baht 666,332,580.00 from the exceeding 666,332,580.00 newly issued ordinary shares with a par

issuing and allocating not more than 888,443,440.00 new ordinary shares with a par value of Baht 1 per share as follows: 1) To capital increase by the General Mandate of Baht 666,332,580.00 from the

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

. (“Trans.Ad”) at the price of Baht 110 per share, totaling of Baht 9.90 million from the shareholders of Trans.Ad (the “Sellers”) who are not the related persons of the Company (the “Transaction”). This

158.90 12.88 154.65 11.63 4.25 2.75 Remarks: * Management means the director, chief executive officer or the next four executives succeeding the chief executive officer, the persons holding equivalent

persons holding equivalent position to the fourth executive and shall include the persons holding the position of manager or equivalent in accounting or finance departments. The Corporate Group’s total

, the total transaction value shall be equivalent to 39.91% calculated based on the Net Profit which is the basis that results in the highest transaction value, from the Consolidated Financial Statement

core company distributing mobile phone and its accessories was affected by competition from competitors in the industry. The sales in previous year were equivalent to 9,202 million baht. The number of

, 2017 – December 31st, 2017) to Shareholders at the rate 0.06 Baht per share. Derived from profit under BOI business at the rate 0.01 Baht per share with total amount of 6,584,343.00 Baht (Six million

, increased by 7.20% compared to last year. As a result, the Company reported net profit of Baht 65.98 million, decreased by 30.23% from last year. Earnings per share presented at Baht 3.09. Statement of